Dopamine beta-Hydroxylase
"Dopamine beta-Hydroxylase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
Descriptor ID |
D004299
|
MeSH Number(s) |
D08.811.682.690.708.292
|
Concept/Terms |
Dopamine beta-Hydroxylase- Dopamine beta-Hydroxylase
- Dopamine beta Hydroxylase
- beta-Hydroxylase, Dopamine
- Dopamine beta-Monooxygenase
- Dopamine beta Monooxygenase
- beta-Monooxygenase, Dopamine
|
Below are MeSH descriptors whose meaning is more general than "Dopamine beta-Hydroxylase".
Below are MeSH descriptors whose meaning is more specific than "Dopamine beta-Hydroxylase".
This graph shows the total number of publications written about "Dopamine beta-Hydroxylase" by people in this website by year, and whether "Dopamine beta-Hydroxylase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2006 | 0 | 1 | 1 |
2010 | 1 | 1 | 2 |
2012 | 3 | 0 | 3 |
2013 | 4 | 1 | 5 |
2014 | 2 | 0 | 2 |
2015 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dopamine beta-Hydroxylase" by people in Profiles.
-
Pharmacogenetics of Dopamine ?-Hydroxylase in cocaine dependence therapy with doxazosin. Addict Biol. 2019 05; 24(3):531-538.
-
Association between DBH 19bp insertion/deletion polymorphism and cognition in schizophrenia with and without tardive dyskinesia. Schizophr Res. 2017 04; 182:104-109.
-
Generation of Two Noradrenergic-Specific Dopamine-Beta-Hydroxylase-FLPo Knock-In Mice Using CRISPR/Cas9-Mediated Targeting in Embryonic Stem Cells. PLoS One. 2016; 11(7):e0159474.
-
Association between D?H 5'-insertion/deletion polymorphism and cognition in patients with chronic schizophrenia. J Clin Psychiatry. 2016 Mar; 77(3):379-85.
-
Exploring possible association between D?H genotype (C1021T), early onset of conduct disorder and psychopathic traits in juvenile delinquents. Eur Arch Psychiatry Clin Neurosci. 2016 Dec; 266(8):771-773.
-
Evaluation of the dopamine ?-hydroxylase (D?H) inhibitor nepicastat in participants who meet criteria for cocaine use disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jun 03; 59:40-48.
-
Possible association between DBH 19 bp insertion/deletion polymorphism and clinical symptoms in schizophrenia with tardive dyskinesia. J Neural Transm (Vienna). 2015 Jun; 122(6):907-14.
-
Examining the utility of using genotype and functional biology in a clinical pharmacology trial: pilot testing dopamine ?-hydroxylase, norepinephrine, and post-traumatic stress disorder. Psychiatr Genet. 2014 Aug; 24(4):181-2.
-
The influence of dopamine ?-hydroxylase gene polymorphism rs1611115 on levodopa/carbidopa treatment for cocaine dependence: a preliminary study. Pharmacogenet Genomics. 2014 Jul; 24(7):370-3.
-
The interaction of polymorphisms of IL10 and DBH was associated with general symptoms of PANSS with TD in Chinese Han schizophrenic patients. PLoS One. 2013; 8(8):e70963.